[Modulated extremely high frequency electromagnetic radiation of low intensity activates or inhibits respiratory burst in neutrophils depending on modulation frequency].
← Research streamLow-intensity EHF electromagnetic radiation affected the synergistic activation of respiratory burst in mouse peritoneal neutrophils in a frequency- and modulation-dependent manner. Continuous EHF EMR (50 microW/cm2) inhibited the synergistic reaction with a …
Study snapshot
Abstract
The influence of low-intensity modulated electromagnetic radiation of extremely high frequencies (EHF EMR) on synergistic reaction of calcium ionophore A23187 and phorbol ester PMA in activation of the respiratory burst of the peritoneal neutrophils of mice line NMRI was investigated. The production of reactive oxygen species by the neutrophils was estimated by luminol-dependent chemiluminescence technique. The cells were irradiated in the far field zone of the channel radiator for 20 min in the presence of A23187 and then were activated by PMA after switching off the irradiation. It was shown, that continuous EHF EMR (50 microW/cm2) inhibited quasi-resonantly the synergistic reaction. The maximum effect was about 25% at carrier frequency of 41.95 GHz. Modulated radiation with carrier frequency of 41.95 GHz and modulation frequency of 1 Hz activated the synergistic reaction, but at modulation frequencies of 0.1, 16 and 50 Hz inhibited one. At fixed modulation frequency of 1 Hz the nonlinear dependence of the effect on the carrier frequency was found. The synergistic reaction was activated in the frequency range of 41.95-42.05 GHz and was inhibited at the frequencies of 41.8-41.9 GHz. The effect was observed only at raised intracellular free calcium concentration and at calcium fluxes through plasma membrane. The obtained results prove the possibility of control over cell functioning by low-intensity modulated EHF EMR, presumably, manipulating by connected systems of enzyme reactions.
AI evidence extraction
Structured fields below were generated from the paper’s abstract and metadata to make the evidence easier to inspect. Automated extraction may be incomplete or incorrect; verify important details against the original paper.
Main findings
Low-intensity EHF electromagnetic radiation affected the synergistic activation of respiratory burst in mouse peritoneal neutrophils in a frequency- and modulation-dependent manner. Continuous EHF EMR (50 microW/cm2) inhibited the synergistic reaction with a maximum effect of about 25% at a carrier frequency of 41.95 GHz. With a 41.95 GHz carrier, 1 Hz modulation activated the reaction, while 0.1, 16, and 50 Hz modulation inhibited it; at 1 Hz modulation, activation occurred at 41.95–42.05 GHz and inhibition at 41.8–41.9 GHz.
Outcomes measured
- Respiratory burst / reactive oxygen species production (luminol-dependent chemiluminescence)
- Synergistic activation response to calcium ionophore A23187 + PMA
Limitations
- Sample size not reported in abstract
- Study conducted in mouse neutrophils (cell preparation), limiting direct human relevance
- Exposure metric reported as power density (microW/cm2); SAR not provided
- Details of randomization/blinding and experimental replication not provided in abstract
View raw extracted JSON
{
"study_type": "animal",
"exposure": {
"band": "mmWave",
"source": "other",
"frequency_mhz": 41950,
"sar_wkg": null,
"duration": "20 min"
},
"population": "Peritoneal neutrophils from NMRI mice (in vitro/ex vivo cell preparation)",
"sample_size": null,
"outcomes": [
"Respiratory burst / reactive oxygen species production (luminol-dependent chemiluminescence)",
"Synergistic activation response to calcium ionophore A23187 + PMA"
],
"main_findings": "Low-intensity EHF electromagnetic radiation affected the synergistic activation of respiratory burst in mouse peritoneal neutrophils in a frequency- and modulation-dependent manner. Continuous EHF EMR (50 microW/cm2) inhibited the synergistic reaction with a maximum effect of about 25% at a carrier frequency of 41.95 GHz. With a 41.95 GHz carrier, 1 Hz modulation activated the reaction, while 0.1, 16, and 50 Hz modulation inhibited it; at 1 Hz modulation, activation occurred at 41.95–42.05 GHz and inhibition at 41.8–41.9 GHz.",
"effect_direction": "mixed",
"limitations": [
"Sample size not reported in abstract",
"Study conducted in mouse neutrophils (cell preparation), limiting direct human relevance",
"Exposure metric reported as power density (microW/cm2); SAR not provided",
"Details of randomization/blinding and experimental replication not provided in abstract"
],
"evidence_strength": "low",
"confidence": 0.74,
"peer_reviewed_likely": "yes",
"keywords": [
"extremely high frequency",
"EHF",
"millimeter wave",
"modulated electromagnetic radiation",
"41.95 GHz",
"power density 50 microW/cm2",
"neutrophils",
"respiratory burst",
"reactive oxygen species",
"chemiluminescence",
"A23187",
"PMA",
"calcium dependence"
],
"suggested_hubs": [
{
"slug": "mmwave-bioeffects",
"weight": 0.9,
"reason": "Examines biological effects of low-intensity EHF/mmWave exposure around 42 GHz with modulation-dependent outcomes."
}
]
}AI-extracted fields are generated from the abstract and metadata and may be incomplete or incorrect. This material is for informational purposes and is not medical advice.
Identifiers and source
DOI: Not supplied
PubMed: 9410041
Related papers
- Extremely High Frequency EMF Facilitate Electrical Signal Propagation by Increasing Transmembrane Potassium Efflux in Artificial Axon Model 2018
- [The use of extremely high frequency electromagnetic fields during acute period of ischemic stroke]. 2001
- [Effect of hypokinetic stress and low intensity electromagnetic field of extremely high frequency on changes of cytokine concentration in rat blood]. 2005
- The phorbol 12-myristate 13-acetate (PMA)-induced oxidative burst in rat peritoneal neutrophils is increased by a 0.1 mT (60 Hz) magnetic field. 1995
- The human skin as a sub-THz receiver - Does 5G pose a danger to it or not? 2018
- [The efficacy in using an extremely high-frequency electromagnetic field in the combined treatment of chronic bronchitis patients]. 1997